Recruiting PHASE1/PHASE2 INTERVENTIONAL 3-arm NCT05985863

Human Umbilical Cord Mesenchymal Stem Cell Transplantation for The Treatment of Acute-on-Chronic Liver Failure

Clinical Research of Human Umbilical Cord Mesenchymal Stem Cell Transplantation for The Treatment of Acute-on-Chronic Liver Failure

Sponsor: Beijing 302 Hospital

Conditions Acute-On-Chronic Liver Failure

Interventions Placebo hUC-MSC hUC-MSC_Prolonged standard medical treatment

Updated 5 times since 2023 Last updated: May 6, 2024 Started: Sep 30, 2023 Primary completion: Dec 30, 2026 Completion: Dec 30, 2028

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05985863, this PHASE1/PHASE2 trial focuses on Acute-On-Chronic Liver Failure and remains actively recruiting participants. Sponsored by Beijing 302 Hospital, it has been updated 5 times since 2023, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Recruiting PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Recruiting PHASE1/PHASE2

Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Jun 2024 — Jul 2024 [monthly]

Recruiting PHASE1_PHASE2

Status: Not Yet Recruiting → Recruiting
Oct 2023 — Jun 2024 [monthly]

Not Yet Recruiting PHASE1_PHASE2
Sep 2023 — Oct 2023 [monthly]

Not Yet Recruiting PHASE1_PHASE2

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Beijing 302 Hospital
BeijingYouan Hospital
Shen Zhen Wingor Biotechnology CO. LTD
Shenzhen Third People's Hospital
Shulan (Hang Zhou) Hospital

Data source: Beijing 302 Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Beijing, China